Orange, CT, United States of America

Li-Mou Zheng



Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Li-Mou Zheng

Introduction

Li-Mou Zheng is a notable inventor based in Orange, Connecticut, who has made significant contributions to the field of cancer treatment. His innovative approach focuses on combination therapies that enhance the effectiveness of existing treatments. With a patent to his name, Zheng is dedicated to advancing medical science and improving patient outcomes.

Latest Patents

Zheng holds a patent for a method titled "Combination therapy comprising cloretazine." This invention provides a method for treating tumors in subjects by administering an effective amount of VNP40101M, or its equivalent, along with a nucleoside or a nucleoside analog. Additionally, the patent outlines a method for inhibiting tumor cell growth by contacting the tumor cells with effective amounts of the same compounds. This groundbreaking work is aimed at enhancing cancer treatment protocols.

Career Highlights

Throughout his career, Li-Mou Zheng has been associated with Vion Pharmaceuticals, Inc., where he has contributed to the development of innovative cancer therapies. His work is characterized by a commitment to research and a focus on improving therapeutic strategies for patients battling cancer.

Collaborations

Zheng has collaborated with esteemed colleagues in the field, including Ivan C. King and Mario Sznol. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and the advancement of cancer research.

Conclusion

Li-Mou Zheng's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving patient care. His work at Vion Pharmaceuticals, Inc. and collaborations with other experts highlight the importance of teamwork in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…